Monopar Therapeutics Inc
(MNPR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,435 | -10,516 | -7,619 | -5,220 | -2,457 |
| Other Working Capital | -313 | 1,646 | 445 | 584 | -511 |
| Other Operating Activity | 476 | 1,641 | 1,248 | 857 | 500 |
| Operating Cash Flow | $-2,271 | $-7,229 | $-5,927 | $-3,778 | $-2,468 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -983 | -4,919 | N/A | N/A | N/A |
| Investing Cash Flow | $-983 | $-4,919 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 822 | 110 | 0 | 0 | N/A |
| Other Financing Activity | -17 | -77 | -106 | -82 | -17 |
| Financing Cash Flow | $805 | $33 | $-106 | $-82 | $-17 |
| Exchange Rate Effect | -11 | -4 | 45 | 20 | -1 |
| Beginning Cash Position | 8,186 | 20,304 | 20,304 | 20,304 | 20,304 |
| End Cash Position | 5,726 | 8,186 | 14,317 | 16,464 | 17,819 |
| Net Cash Flow | $-2,461 | $-12,118 | $-5,987 | $-3,840 | $-2,485 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,271 | -7,229 | -5,927 | -3,778 | -2,468 |
| Free Cash Flow | -2,271 | -7,229 | -5,927 | -3,778 | -2,468 |